Name | uridine triacetate | CAS# | 4105-38-8 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Uridine triacetate is a drug used in the treatment of hereditary orotic aciduria and to treat patients following an overdose of chemotherapy drugs 5-fluorouracil or capecitabine, or in patients exhibiting early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of 5-fluorouracil or capecitabine administration. Uridine triacetate was granted breakthrough therapy designation by FDA in 2015. Uridine triacetate is a prodrug of uridine. |
Get all suppliers by the below link:
2024-07-15 |
uridine triacetate
Price: Inquiry |
2019-03-05 |
uridine triacetate
Price: ¥198.0 |
2020-12-18 |
PN401
Price: $Inquiry |
2021-07-26 |
2',3',5'-Triacetyluridine
Price: $Inquiry |
2024-01-09 |
2',3',5'-Triacetyluridine
Price: $Inquiry |
2022-11-03 |
uridine triacetate
Price: ¥720.0 |
2021-04-03 |
2',3',5'-Triacetyluridine
Price: ¥747.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved